Collegium Pharmaceutical
COLL
COLL
230 hedge funds and large institutions have $1.28B invested in Collegium Pharmaceutical in 2024 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 93 increasing their positions, 76 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.66% less ownership
Funds ownership: 123.87% → 121.21% (-2.7%)
17% less capital invested
Capital invested by funds: $1.54B → $1.28B (-$259M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
230
Holding in Top 10
1
Calls
$2.04M
Puts
$599K
Top Buyers
| 1 | +$26.5M | |
| 2 | +$16.1M | |
| 3 | +$10M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$9.38M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$7.15M |
Top Sellers
| 1 | -$33.1M | |
| 2 | -$21.8M | |
| 3 | -$17.7M | |
| 4 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$9.53M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$7.87M |